841 LBL-019, a novel TNFR2 agonist antibody, shows potent anti-tumor efficacy through preferentially activating CD8+ T cells and alleviating the suppressive effect of Treg cells
| Autor: | Tingting Li, Peng Zhang, Xiao Huang, Jing Guan, Hailin Wang, Huan Lin, Baohui Wang, Jianming Sun, Yujia Dan, Yurong Qin, Guojin Wu, Xiaofan Hou, Shoupeng Lai, Xiaoqiang Kang, Hong Ling |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2023-SITC2023.0841 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|